Figure 11From: Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapyIn vivo bioavailability of curcumin using PLGA-CURC nanoparticles. PLGA-CURC were administered intravenously to the rats at a dose of 7.5 mg/kg (n = 6).Back to article page